98 related articles for article (PubMed ID: 25933593)
1. PMA-SiO2 catalyzed synthesis of indolo[2,3-c]quinolines as potent anti cancer agents.
Srihari P; Padmabhavani B; Ramesh S; Bharath Kumar Y; Singh A; Ummanni R
Bioorg Med Chem Lett; 2015 Jun; 25(11):2360-5. PubMed ID: 25933593
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and anticancer activity of some novel indolo[3,2-b]andrographolide derivatives as apoptosis-inducing agents.
Song Y; Xin Z; Wan Y; Li J; Ye B; Xue X
Eur J Med Chem; 2015 Jan; 90():695-706. PubMed ID: 25506809
[TBL] [Abstract][Full Text] [Related]
4. SYNTHESIS AND CYTOTOXIC ACTIVITY OF NEW 5H-INDOLO[2,3-B]QUINOLINE O-AMINOGLYCOSIDES.
Badowska-Rosłonek K; Ciesielska A; Switalska M; Piskozub M; Peczyńska-Czoch W; Wietrzyk J; Kaczmarek Ł
Acta Pol Pharm; 2016; 73(3):683-92. PubMed ID: 27476287
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-cancer activity of 1,4-disubstituted imidazo[4,5-c]quinolines.
Thigulla Y; Akula M; Trivedi P; Ghosh B; Jha M; Bhattacharya A
Org Biomol Chem; 2016 Jan; 14(3):876-83. PubMed ID: 26592542
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
Primik MF; Göschl S; Jakupec MA; Roller A; Keppler BK; Arion VB
Inorg Chem; 2010 Dec; 49(23):11084-95. PubMed ID: 20979395
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and antitumour activity of bisquinoline derivatives connected by 4-oxy-3-fluoroaniline moiety.
Li S; Huang Q; Liu Y; Zhang X; Liu S; He C; Gong P
Eur J Med Chem; 2013 Jun; 64():62-73. PubMed ID: 23644189
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro antiproliferative effect of novel quinoline-based potential anticancer agents.
Arafa RK; Hegazy GH; Piazza GA; Abadi AH
Eur J Med Chem; 2013 May; 63():826-32. PubMed ID: 23584545
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and structure-activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents.
Tang Q; Zhao Y; Du X; Chong L; Gong P; Guo C
Eur J Med Chem; 2013 Nov; 69():77-89. PubMed ID: 24012712
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of anti-breast cancer agents from 4-piperazinylquinoline: a hybrid pharmacophore approach.
Solomon VR; Hu C; Lee H
Bioorg Med Chem; 2010 Feb; 18(4):1563-72. PubMed ID: 20106668
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and biological evaluation of artemisinin-indoloquinoline hybrids as potent antiproliferative agents.
Wang L; Świtalska M; Wang N; Du ZJ; Fukumoto Y; Diep NK; Kiguchi R; Nokami J; Wietrzyk J; Inokuchi T
Molecules; 2014 Nov; 19(11):19021-35. PubMed ID: 25412047
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of aminodihydroquinoline analogs: identification of novel proapoptotic agents.
Lee E; Han S; Jin GH; Lee HJ; Kim WY; Ryu JH; Jeon R
Bioorg Med Chem Lett; 2013 Jul; 23(13):3976-8. PubMed ID: 23684895
[TBL] [Abstract][Full Text] [Related]
13. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives.
He L; Chang HX; Chou TC; Savaraj N; Cheng CC
Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920
[TBL] [Abstract][Full Text] [Related]
14. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors.
Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L
Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121
[TBL] [Abstract][Full Text] [Related]
15. Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.
Sidoryk K; Jaromin A; Edward JA; Świtalska M; Stefańska J; Cmoch P; Zagrodzka J; Szczepek W; Peczyńska-Czoch W; Wietrzyk J; Kozubek A; Zarnowski R; Andes DR; Kaczmarek Ł
Eur J Med Chem; 2014 May; 78():304-13. PubMed ID: 24686017
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and evaluation of cytotoxicity of novel chromeno[4,3-b]quinoline derivatives.
Miri R; Motamedi R; Rezaei MR; Firuzi O; Javidnia A; Shafiee A
Arch Pharm (Weinheim); 2011 Feb; 344(2):111-8. PubMed ID: 21290427
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of antitumor activity of novel N-acyllavendamycin analogues and quinoline-5,8-diones.
Behforouz M; Cai W; Mohammadi F; Stocksdale MG; Gu Z; Ahmadian M; Baty DE; Etling MR; Al-Anzi CH; Swiftney TM; Tanzer LR; Merriman RL; Behforouz NC
Bioorg Med Chem; 2007 Jan; 15(1):495-510. PubMed ID: 17035024
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antitumor cytotoxicity evaluation of pyrido[4,3,2-de]quinolines and isoquinolino[6,5,4,3-cde]quinolines.
Ding Q; Jia G; Lown JW
Anticancer Drug Des; 2000 Apr; 15(2):99-108. PubMed ID: 10901297
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular modeling and biological evaluation of 2-aminomethyl-5-(quinolin-2-yl)-1,3,4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent.
Sun J; Zhu H; Yang ZM; Zhu HL
Eur J Med Chem; 2013 Feb; 60():23-8. PubMed ID: 23279864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
